StonvexLoading…
StonvexStonvexStonvexCore line items from MSCI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.13B | $2.86B | $2.53B | $2.25B |
Operating Income | $1.71B | $1.53B | $1.38B | $1.21B |
Net Income | $1.20B | $1.11B | $1.15B | $870.57M |
EPS (Diluted) | $15.69 | $14.05 | $14.39 | $10.72 |
Total Assets | $5.70B | $5.45B | $5.52B | $5.00B |
Total Liabilities | $8.36B | $6.39B | $6.26B | $6.01B |
Cash & Equivalents | $515.33M | $409.35M | $461.69M | $993.56M |
Free Cash Flow OCF − CapEx | $1.55B | $1.47B | $1.21B | $1.08B |
Shares Outstanding | 73.56M | 77.74M | 79.09M | 79.96M |